Isoginkgetin targets PLEKHA5 and suppresses PI3K/AKT/mTOR signaling in esophageal squamous cell carcinoma
Aim of the study This study investigated the antitumor activity of isoginkgetin (IGK), a biflavonoid derived from Ginkgo biloba L., in esophageal squamous cell carcinoma (ESCC). Methods CCK-8, colony formation, EdU incorporation, wound-healing, Transwell, and flow-cytometric assays were used to characterize IGK-induced phenotypes. Integrated transcriptomic and data-independent acquisition proteomic analyses were used for abundance-based molecular profiling, while targeted antibody-based phosphorylation-array profiling was analyzed as a separate signaling-activity layer. Molecular docking and 100-ns molecular dynamics simulations assessed binding plausibility. SPR quantified direct IGK-PLEKHA5 binding, CETSA assessed IGK-dependent PLEKHA5 thermal stabilization, PLEKHA5 -overexpression experiments tested functional relevance, and a nude-mouse subcutaneous xenograft model assessed in vivo antitumor activity and tolerability within the measured endpoints. Results IGK inhibited ESCC cell proliferation, colony formation, migration, and invasion and induced G2/M arrest and apoptosis. Transcriptomic and proteomic profiles primarily reflected broad changes in cell-cycle, DNA-repair, p53-associated, and stress-response programs. Targeted phosphorylation-array analysis and immunoblotting showed reduced AKT and mTOR phosphorylation, together with changes in MAPK/ERK, GSK3α, and CREB-related signals. Cross-platform analysis showed significantly reduced PLEKHA5 protein abundance, accompanied by a downward trend in PLEKHA5 transcript expression. SPR showed concentration-dependent IGK-PLEKHA5 binding with an apparent equilibrium dissociation constant (K D ) of 9.266 μM, and CETSA showed IGK-dependent thermal stabilization of PLEKHA5. PLEKHA5 overexpression partially restored malignant phenotypes and AKT/mTOR phosphorylation. In vivo , IGK reduced xenograft growth and intratumoral PLEKHA5, p-AKT, p-mTOR, and Ki-67 signals without overt renal injury or increases in the measured inflammatory markers under the tested schedule. Conclusion These findings support PLEKHA5 as a direct binding target of IGK and indicate that PLEKHA5 contributes to the attenuation of AKT/mTOR signaling and the antitumor response in ESCC. The partial rescue following PLEKHA5 overexpression further suggests that additional IGK-responsive mechanisms are also involved.
Authors
- Boshi Fan
- Taiqian Gong (ORCID: https://orcid.org/0000-0003-4193-7804)
- Shouyin Di (ORCID: https://orcid.org/0000-0002-5704-259X)
- Shun Xie (ORCID: https://orcid.org/0009-0008-1523-0972)
- Qiu Li (ORCID: https://orcid.org/0000-0003-3079-1352)
- Xuben Niu
- Wenting Song (ORCID: https://orcid.org/0009-0002-1174-0285)
- Yanxin Dong (ORCID: https://orcid.org/0009-0007-5668-3321)
- Jiale Zhang
Institutions
- Chinese PLA General Hospital (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fphar.2026.1873431
- Primary Topic
- Biological Activity of Diterpenoids and Biflavonoids
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China